People on sodium-glucose cotransporter2 (SGLT2) inhibitors were twice as likely to require a lower limb amputation as people taking another type of diabetes medication, Scandinavian researchers have found.
from WebMD Health https://ift.tt/2z9CwRh
Social Profiles
0 comments:
Post a Comment